Xeris Biopharma Holdings, Inc. (XERS) analyst actions
Rating and price-target actions on XERS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the XERS overview →
No XERS analyst action events in the measured window.
Nothing matched in the current window — the XERS overview has every event we measure for this name.
Get an email when XERS moves on news →Keep exploring
More XERS: earnings → · SEC filings → · XERS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | 256 | +0.04% | 57% |
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
| Cerus Corporation (CERS) | 255 | +0.09% | 52% |
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.